Clinical use of erythromycin in children with gastrointestinal dysmotility.
Article
in English
| IMSEAR
| ID: sea-40515
ABSTRACT
Intolerant feeding is a common symptom in gastrointestinal disorders which is commonly found in systemic diseases. Prokinetic drugs play a role in management. A low dose of erythromycin has an effect on improvement of antroduodenal motility and gastric emptying in children and adults. The objective of this study was to evaluate the efficacy of intravenous erythromycin in the treatment of GI dysmotility in children. Retrospective studies were performed in the Department of Pediatrics, Siriraj Hospital, Mahidol University between 1996 and 2000 in 22 patients with intolerance of feeding due to GI dysmotility. Their ages ranged from 11 days to 12 years (42.1 +/- 48.1 months). The patients were divided into 2 groups 12 critically ill and 10 non-critically ill patients. Dosages of intravenous erythromycin were 1-3 mg/kg/dose every 6 hours. The result of treatment was evaluated as good (tolerant feeding), fair (tolerant feeding but needing erythromycin for longer than 1 month) and failed (intolerant feeding). All non-critically ill patients had improved symptoms with 9 +/- 4.3 days duration of treatment. In the other group, 8 patients had good results with 10.9 +/- 6 days of treatment. Two patients needed the drug for longer than 1 month and the other 2 patients did not respond and died due to severe infection. Low dose intravenous erythromycin had good efficacy in the treatment of intolerant feeding related to GI dysmotility in children.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Gastrointestinal Agents
/
Female
/
Humans
/
Male
/
Infant, Newborn
/
Child
/
Child, Preschool
/
Erythromycin
/
Retrospective Studies
/
Gastric Emptying
Type of study:
Observational study
Language:
English
Year:
2001
Type:
Article
Similar
MEDLINE
...
LILACS
LIS